이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Medical Disposables & Supplies 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Kurt Boothe

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.6yrs
CEO 소유권	19.4%
경영진 평균 재임 기간	3.7yrs
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

CEO

Kurt Boothe

3.6yrs

테뉴어

Mr. Kurt Boothe was a Company Secretary and General Manager of Medical Disposables & Supplies Limited until November 01, 2020 and serves as Executive Director. He serves as Chief Executive Officer of Medic...

리더십 팀

이름	위치	테뉴어	보상	소유권
Kurt Boothe	CEO & Executive Director	3.6yrs	데이터 없음	19.44% JMD 112.5m
Myrtis Boothe	Founder & Executive Director	no data	데이터 없음	19% JMD 110.0m
Raymond Ernandez	Chief Financial Officer	no data	데이터 없음	데이터 없음
Bertino Gordon	Operations Manager	4.3yrs	데이터 없음	데이터 없음
Nadine Banton	Human Resource & Administrative Manager	3.7yrs	데이터 없음	데이터 없음
Nikeisha Hill	Executive Director	no data	데이터 없음	19% JMD 110.0m

3.7yrs

평균 재임 기간

경험이 풍부한 관리: MDS 의 관리팀은 경험 ( 3.7 년 평균 재직 기간)으로 간주됩니다.

Medical Disposables & Supplies 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Less than half of directors are independent

Less than half of directors are independent

Recent updates

New minor risk - Share price stability

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

New major risk - Share price stability

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

Investor sentiment deteriorates as stock falls 24%

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Investor sentiment improves as stock rises 22%

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Upcoming dividend of JA$0.09 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JA$0.07 per share

First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021)

Full year 2021 earnings released

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: JA$4.74

Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020)

Second quarter 2021 earnings released: JA$0.02 loss per share

Market pulls back on stock over the past week

New 90-day low: JA$4.30

New 90-day low - JA$4.67

First quarter earnings released

New 90-day low - JA$5.07

CEO

테뉴어

리더십 팀

평균 재임 기간